Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study.
2型糖尿病患者心臟衰竭的盛行率和發病率:來自全國性前瞻性群眾研究DIABET-IC研究的結果。
Cardiovasc Diabetol 2024-07-16
Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort data.
鈉-葡萄糖共轉運蛋白 2 抑制劑降低心衰竭無糖尿病患者發生 2 型糖尿病的風險:一項真實世界隊列數據的分析。
Diabetes Obes Metab 2024-08-07
Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study.
使用 NT-proBNP 偵測患有 2 型糖尿病及高血壓或高正常血壓患者的心臟壓力:一項橫斷面多中心研究。
Cardiovasc Diabetol 2024-08-12
Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure.
心衰竭與糖尿病之間雙向關係的證據:在心衰竭患者中檢測葡萄糖異常和預防糖尿病的策略。
Cardiovasc Diabetol 2024-09-28
Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis.
SGLT-2 抑制劑對於 2 型糖尿病心衰竭的保護影響:透過縱向臨床資料庫分析。
J Clin Med 2024-12-17
Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure.
急性住院心衰竭患者中 SGLT2 抑制劑啟動的發生率及潛在預測因子。
Am J Health Syst Pharm 2025-02-05
Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus.
Sitagliptin、糖尿病與心臟衰竭:對糖尿病患者中 sitagliptin 治療與心臟衰竭的深入回顧。
Diabetol Int 2025-04-01